ERBB2 and breast cancer: On the other hand, our data have shown that delivery of selective siRNAs via carbonate apatite nanoparticle against the mRNA transcripts of the growth receptors including Estrogen Receptor 1 (ESR1) along with anti-apoptotic genes (BCL2), or with ERBB2 and EGFR, critically contributes to the induction of cell deaths in human and murine breast cancer cell lines by inhibiting the activation of MAPK and PI3K pathways [82].